Previous Close | 13.61 |
Open | 13.58 |
Bid | 12.76 x 100 |
Ask | 12.90 x 300 |
Day's Range | 12.75 - 14.44 |
52 Week Range | 4.60 - 20.90 |
Volume | |
Avg. Volume | 386,173 |
Market Cap | 564.64M |
Beta (5Y Monthly) | 0.77 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript May 8, 2024 Y-mAbs Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to Y-mAbs Therapeutics Inc. Earnings Conference Call for the First Quarter of 2024. […]
Amidst leadership changes and competitive pressures, Y-mAbs Therapeutics Inc reports robust U.S. sales growth and strategic global expansions.
Q1 2024 Y-mAbs Therapeutics Inc Earnings Call